Ready-To-Use Luria-Bertani (LB) Liquid Medium Market Report 2025

This ready-to-use luria-bertani (LB) liquid medium market report delivers an in-depth analysis of the market’s key characteristics, including size, growth potential, and segmentation. It provides a detailed breakdown of the market across major regions and leading countries, highlighting historical data and future growth projections. The report also examines the competitive landscape, market share insights, emerging trends, and strategic developments shaping the market.

The ready-to-use luria-bertani (LB) liquid medium market size has grown strongly in recent years. It will grow from $10.32 billion in 2024 to $11.21 billion in 2025 at a compound annual growth rate (CAGR) of 8.6%. The growth in the historic period can be attributed to growing adoption in pharmaceutical and biotechnology sectors, growing demand for advanced medicines, increasing demand for microbiological research, rising demand for outsourcing R&D activities, and increasing demand for microbiological research.

The ready-to-use luria-bertani (LB) liquid medium market size is expected to see strong growth in the next few years. It will grow to $15.4 billion in 2029 at a compound annual growth rate (CAGR) of 8.2%. The growth in the forecast period can be attributed to growing adoption in pharmaceutical and biotechnology sectors, growing demand for advanced medicines, increasing demand for microbiological research, rising demand for outsourcing R&D activities, increasing demand for microbiological research. Major trends in the forecast period include advancements in customization and packaging, increasing research and development activities, increasing demand for standardized media, rising adoption of automated laboratory systems, and growing preference for pre-formulated solutions.

The growing focus on research and development (R&D) activities is expected to drive the expansion of the ready-to-use Luria-Bertani (LB) liquid medium market in the coming years. R&D activities involve exploring new ideas or technologies and applying the findings to design, test, and refine products or processes. Continuous innovation pushes businesses to invest in R&D to develop new products, enhance existing ones, and stay competitive by addressing evolving consumer demands. Ready-to-use LB liquid medium plays a crucial role in R&D by supporting bacterial growth, gene cloning, protein expression, and various genetic modifications. Its convenience and reliability make it indispensable for a wide range of experimental procedures and large-scale research projects. For example, in September 2023, the National Center for Science and Engineering Statistics, a US-based statistical agency, reported that federal agency obligations for R&D reached a record high of $190.2 billion, reflecting a 13.6% increase ($22.7 billion) from 2021. Thus, the rise in R&D activities is fueling the demand for ready-to-use Luria-Bertani (LB) liquid medium.

The increasing number of clinical trials is also expected to boost the ready-to-use LB liquid medium market. Clinical trials are research studies involving human participants to evaluate the safety and efficacy of new medical treatments before their general release. The rise in clinical trials is driven by the demand for personalized medicine, which seeks to tailor treatments to individual genetic profiles and specific health conditions. Ready-to-use LB liquid medium provides consistent conditions essential for accurate results without the need for preparation or sterilization, thus accelerating the research process, especially in high-throughput and multi-site studies. For instance, in November 2023, the Association of the British Pharmaceutical Industry (ABPI) reported a 4.3% increase in clinical trials initiated in the UK, rising from 394 in 2021 to 411 in 2022. This uptick in clinical trials is contributing to the growth of the ready-to-use LB liquid medium market.

Leading companies in the ready-to-use LB liquid medium market are investing in advancements in drug discovery software to gain a competitive advantage. For example, in December 2023, Merck, a Germany-based company specializing in pharmaceuticals and biotechnology, introduced AIDDISON, a state-of-the-art drug discovery software. AIDDISON utilizes artificial intelligence and machine learning to speed up the identification of potential drug candidates. The software features an intuitive interface and advanced data analysis tools, allowing researchers to process and interpret large datasets more efficiently. This innovative tool is set to transform the drug discovery process, leading to faster and more cost-effective development of new therapeutics.

Major companies operating in the ready-to-use luria-bertani (LB) liquid medium market are Thermo Fisher Scientific Inc., Avantor Inc., Lonza Group AG, Sigma Aldrich Chemicals Pvt. Ltd., Bio-Rad Laboratories Inc., Neogen Corporation, bioWORLD, Hardy Diagnostics Inc., MP Biomedicals LLC, ITW Reagents, Alpha Teknova Inc., HiMedia Laboratories Pvt. Ltd., Scharlab S.L., Interchim, Condalab, Quality Biological Inc., Thomas Scientific LLC, Geno Technology Inc., Central Drug House (P) Ltd., Citotest Labware Manufacturing Co. Ltd., Research Products International, NZYTech Lda.

Europe was the largest region in the ready-to-use Luria-Bertani (LB) liquid medium market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the ready-to-use luria-bertani (LB) liquid medium market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the ready-to-use luria-bertani (LB) liquid medium market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Ready-to-use Luria-Bertani (LB) liquid medium is a pre-prepared, nutrient-rich solution designed for cultivating various bacterial species. Composed of tryptone, yeast extract, and sodium chloride, it requires no additional preparation or sterilization. This medium supports bacterial growth and maintenance in laboratories, providing a convenient and time-efficient solution that ensures consistent experimental results.

The primary types of ready-to-use LB liquid medium are those with antibiotics and those without. LB mediums with antibiotics are formulated to suppress the growth of unwanted microorganisms, allowing only the desired bacteria to grow. These mediums are employed in a range of applications including drug discovery, stem cell technologies, regenerative medicine and tissue engineering, biopharmaceuticals, cancer research, and more. They are utilized by various end-users such as research laboratories, academic institutions, and the biotechnology and pharmaceutical industries.

The ready-to-use Luria-Bertani (LB) liquid medium market research report is one of a series of new reports that provides ready-to-use Luria-Bertani (LB) liquid medium market statistics, including the ready-to-use Luria-Bertani (LB) liquid medium industry global market size, regional shares, competitors with ready-to-use Luria-Bertani (LB) liquid medium market share, detailed ready-to-use Luria-Bertani (LB) liquid medium market segments, market trends, and opportunities, and any further data you may need to thrive in the ready-to-use Luria-Bertani (LB) liquid medium industry. These ready-to-use Luria-Bertani (LB) liquid medium market research reports deliver a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The ready-to-use Luria-Bertani (LB) liquid medium market consists of sales of bacterial growth medium, cell culture medium, transformation medium, and research medium. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.